Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

CLINICURO ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   12.4% 8.5% 12.5% 8.5% 9.6% 8.2% 15.5% 15.3%   Credit score (0-100)   21 30 20 29 24 29 12 2   Credit rating   B B B B B B B B   Credit limit (kDKK)   -0.0 -0.0 -0.0 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   151 428 268 90.4 268 333 0.0 0.0   EBITDA   -150 228 117 -112 -218 -162 0.0 0.0   EBIT   -150 228 117 -112 -218 -162 0.0 0.0   Pre-tax profit (PTP)   -302.6 194.8 97.6 -129.7 -245.3 112.3 0.0 0.0   Net earnings   -266.1 150.9 77.1 -193.8 -245.3 112.3 0.0 0.0   Pre-tax profit without non-rec. items   -303 215 97.6 -130 -245 112 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   -474 -323 -246 78.6 -167 -573 -653 -653   Interest-bearing liabilities   529 482 407 413 762 1,085 653 653   Balance sheet total (assets)   188 293 257 728 708 638 0.0 0.0   Net Debt   529 435 305 403 762 1,085 653 653     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   151 428 268 90.4 268 333 0.0 0.0   Gross profit growth   -30.4% 184.0% -37.3% -66.3% 197.0% 23.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   188 293 257 728 708 638 0 0   Balance sheet change%   -44.9% 56.0% -12.1% 182.6% -2.7% -9.8% -100.0% 0.0%   Added value   -150.1 228.4 117.2 -111.8 -217.6 -162.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -99.6% 53.4% 43.7% -123.7% -81.1% -48.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -2.7% 34.1% 20.9% -18.2% -27.2% -45.5% 0.0% 0.0%   ROI %   -58.8% 47.2% 26.4% -24.9% -34.7% 16.3% 0.0% 0.0%   ROE %   -100.7% 62.8% 28.0% -115.3% -62.4% 16.7% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   -71.6% -52.4% -48.9% 10.8% -19.1% -47.3% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -352.9% 190.4% 260.6% -360.7% -349.9% -669.6% 0.0% 0.0%   Gearing %   -111.7% -149.2% -165.3% 525.6% -456.7% -189.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 4.6% 4.4% 4.4% 4.7% 4.1% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   0.3 0.5 0.4 0.2 0.0 0.0 0.0 0.0   Current Ratio   0.3 0.5 0.5 0.3 0.2 0.3 0.0 0.0   Cash and cash equivalent   0.0 47.2 101.2 9.6 0.0 0.0 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -484.2 -323.1 -246.0 -439.7 -685.0 -885.0 -326.4 -326.4   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -150 228 117 -112 -218 -162 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -150 228 117 -112 -218 -162 0 0   EBIT / employee   -150 228 117 -112 -218 -162 0 0   Net earnings / employee   -266 151 77 -194 -245 112 0 0